Dose History
30 total entries| Date & Time | Who | Peptide | Phase | Units | Dose | Notes |
|---|---|---|---|---|---|---|
| 2026-03-08T10:02 | Scott | Reta-Trutide | Phase 1 | 5 | 500 mcg (0.5 mg) | |
| 2026-03-08T10:02 | Grace | Reta-Trutide | Phase 1 | 5 | 500 mcg (0.5 mg) | |
| 2026-03-08T10:01 | Scott | KLOW | Phase 1 | 5 | ~132–198 mcg | |
| 2026-03-08T00:00 | Scott | Ipamorelin + CJC-1295 | Phase 2 | 3 | ~100 mcg | makeup dose |
| 2026-03-05T22:08 | Scott | Ipamorelin + CJC-1295 | Phase 1 | 2 | ~66 mcg | |
| 2026-03-05T22:08 | Scott | KLOW | Phase 1 | 5 | ~165 mcg BPC/TB/KPV + ~1000 mcg GHK-Cu | |
| 2026-03-04T22:00 | Scott | Ipamorelin + CJC-1295 | Phase 1 | 2 | ~66 mcg | |
| 2026-03-04T21:30 | Scott | KLOW | Phase 1 | 5 | ~165 mcg BPC/TB/KPV + 1000 mcg GHK-Cu | |
| 2026-03-04T21:00 | Scott | Reta-Trutide | Phase 1 | 5 | 500 mcg (0.5 mg) | |
| 2026-03-04T21:00 | Grace | Reta-Trutide | Phase 1 | 5 | 500 mcg (0.5 mg) |
Prev Page 2 of 2